VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,340,000 | +1417.5% | 272,562 | +1267.9% | 0.07% | +1600.0% |
| Q3 2017 | $286,000 | +4.0% | 19,926 | +25.3% | 0.00% | +33.3% |
| Q2 2017 | $275,000 | -11.3% | 15,900 | -43.2% | 0.00% | -25.0% |
| Q1 2017 | $310,000 | -14.6% | 27,996 | +12.0% | 0.00% | 0.0% |
| Q4 2016 | $363,000 | -86.4% | 25,000 | -77.1% | 0.00% | -88.2% |
| Q3 2016 | $2,678,000 | +21.9% | 109,100 | 0.0% | 0.03% | +41.7% |
| Q2 2016 | $2,197,000 | -13.8% | 109,100 | +12.3% | 0.02% | -42.9% |
| Q1 2016 | $2,549,000 | -55.1% | 97,158 | +74.1% | 0.04% | -72.0% |
| Q4 2015 | $5,672,000 | +221.5% | 55,821 | +465.0% | 0.15% | +265.9% |
| Q3 2015 | $1,764,000 | -2.4% | 9,879 | +21.5% | 0.04% | +17.1% |
| Q2 2015 | $1,808,000 | -84.8% | 8,132 | -86.4% | 0.04% | -89.6% |
| Q1 2015 | $11,918,000 | +129.1% | 60,000 | +65.1% | 0.34% | +51.6% |
| Q4 2014 | $5,201,000 | +677.4% | 36,342 | +612.6% | 0.22% | +619.4% |
| Q3 2014 | $669,000 | -10.4% | 5,100 | -13.6% | 0.03% | 0.0% |
| Q2 2014 | $747,000 | +146.5% | 5,904 | +156.7% | 0.03% | +55.0% |
| Q1 2014 | $303,000 | -80.9% | 2,300 | -84.9% | 0.02% | -68.3% |
| Q3 2013 | $1,584,000 | -79.6% | 15,200 | -83.1% | 0.06% | -85.5% |
| Q2 2013 | $7,769,000 | – | 90,129 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |